Simonian Nancy A
SEC-identified person · CIK 1359574 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Generate Biomedicines, Inc. GENB | Director | filed 2026 - 2026 |
| Syros Pharmaceuticals, Inc. SYRS | Director · President and CEO | filed 2016 - 2024 |
| Seagen Inc. SGEN | Director | filed 2012 - 2023 |
| Evelo Biosciences, Inc. EVLO | Director | filed 2018 - 2020 |
| Arqule INC arql | Director | filed 2006 - 2010 |
| Millennium Pharmaceuticals INC MLNM | Chief Medical Officer | filed 2007 - 2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.